| Application of Super-Resolution Ultrasound (SRUS) in Liver Tumor (NCT07707661) | Eastern Hepatobiliary Surgery Hospital | 2026-07-01 |
| Effects of Short-term Perioperative Daidzein Intervention on Liver Histopathology in Patients With MASLD (NCT07623044) | Eastern Hepatobiliary Surgery Hospital | 2026-05-21 |
| A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma (NCT07351513) | Eastern Hepatobiliary Surgery Hospital | 2026-01-30 |
| A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers (NCT07351591) | Eastern Hepatobiliary Surgery Hospital | 2026-01-30 |
| Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer (NCT07363356) | Eastern Hepatobiliary Surgery Hospital | 2026-01-30 |
| A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer (NCT07337031) | Eastern Hepatobiliary Surgery Hospital | 2026-01-01 |
| The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD (NCT07285850) | Eastern Hepatobiliary Surgery Hospital | 2025-10-20 |
| A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma (NCT06902389) | Eastern Hepatobiliary Surgery Hospital | 2025-07-30 |
| QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors (NCT06892925) | Eastern Hepatobiliary Surgery Hospital | 2025-06-14 |
| Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer (NCT06818773) | Eastern Hepatobiliary Surgery Hospital | 2025-02-01 |
| HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC (NCT07364305) | Eastern Hepatobiliary Surgery Hospital | 2025-01-01 |
| Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma (NCT06530823) | Eastern Hepatobiliary Surgery Hospital | 2024-08-01 |
| Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma (NCT05925413) | Eastern Hepatobiliary Surgery Hospital | 2023-04-24 |
| Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC (NCT06013943) | Eastern Hepatobiliary Surgery Hospital | 2023-03-17 |
| A Study of Danning Tablet in Patients With Polypoid Lesions of Gallbladder (NCT05668871) | Eastern Hepatobiliary Surgery Hospital | 2022-12-01 |
| AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary Tract Cancer (ASCEND-BTC) (NCT05667350) | Eastern Hepatobiliary Surgery Hospital | 2022-02-28 |
| Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer (NCT05540925) | Eastern Hepatobiliary Surgery Hospital | 2022-01-01 |
| Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis (NCT04523402) | Eastern Hepatobiliary Surgery Hospital | 2020-12-31 |
| Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma (NCT04523467) | Eastern Hepatobiliary Surgery Hospital | 2020-12-01 |
| Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma (NCT04386772) | Eastern Hepatobiliary Surgery Hospital | 2020-05-27 |
| Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma (NCT03702491) | Eastern Hepatobiliary Surgery Hospital | 2018-08-10 |
| Prospective Surveillance for Very Early Hepatocellular Carcinoma (NCT03588442) | Eastern Hepatobiliary Surgery Hospital | 2018-07-15 |
| Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma (NCT03515369) | Eastern Hepatobiliary Surgery Hospital | 2018-05-01 |